N9 - Neuroscience in the Clinic: Afferent and Efferent Visual Pathway Manifestations of Neurodegenerative Diseases: Implications for Diagnosis and Treatment

Event Time: Friday April 28, 2017 1:00 pm to 3:00 pm
Topic(s): Movement Disorders, Neuro-ophthalmology/Neuro-otology
Director(s): Heather Moss MD, PhD, FAAN, Gregory Van Stavern MD, FAAN
Description: Neurodegenerative diseases, particularly dementing disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD), are increasing in prevalence, related in part to the aging of the population. Visual dysfunction is an under-recognized and important cause of overall neurologic disability and reduced quality of life in neurodegenerative diseases. This program will review visual dysfunction (including the afferent and efferent systems as well as the cognitive visual manifestations of disease) in several neurodegenerative disorders, with special focus on clinical neuro-ophthalmic testing and vision disability in AD and PD and other neurodegenerative conditions. This will be achieved with faculty presentations on clinical aspects, scientific aspects and abstract presentations. The aim is to increase recognition of the types of visual dysfunction that occur in association with neuro-degenerative diseases, as well as the causes, impact on quality of life, and the steps in evaluation and treatment in patients who experience these symptoms.
Completion Message: Participants should be familiar with patterns of afferent and efferent visual dysfunction in patients with neuro-degenerative disease, understand an approach to diagnosis and treatment of resulting visual symptoms and get an update on new break-throughs in the field.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Systems-Based Practice

Abstract Presenters

Start Time Pub. Title Presenter
1:35 PM 001 Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults Michael Ward, MD, PhD
Disclosure:
Dr. Ward has nothing to disclose.

2:15 PM 002 What are the phenotypes of Brazilian patients with autossomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)?: Neurological, ophthalmological and neuroimaging features of seven genetically confirmed cases. Flavio Rezende Filho
Disclosure:
Dr. Rezende Filho has nothing to disclose.

Register Now

Related Courses